title: A case of Behçet's disease with pulmonary arterial aneurysm and secondary amyloidosis.
authors.forename: K
authors.initials: K
authors.lastname: Aksu
authors.forename: H
authors.initials: H
authors.lastname: Koçanaoğullari
authors.forename: G
authors.initials: G
authors.lastname: Keser
authors.forename: V
authors.initials: V
authors.lastname: Inal
authors.forename: Y
authors.initials: Y
authors.lastname: Kabasakal
authors.forename: F
authors.initials: F
authors.lastname: Oksel
authors.forename: G
authors.initials: G
authors.lastname: Gümüşdiş
authors.forename: E
authors.initials: E
authors.lastname: Doğanavşargil
mesh_terms: D000686:Amyloidosis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D000783:Aneurysm / Q000150:complications / Q000378:metabolism / Q000473:pathology*; D001241:Aspirin / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D003078:Colchicine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011651:Pulmonary Artery / Q000378:metabolism / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D001241:Aspirin; D003078:Colchicine